Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban - PubMed (original) (raw)
. 2003 Feb 28;299(5611):1410-3.
doi: 10.1126/science.1081578.
Affiliations
- PMID: 12610310
- DOI: 10.1126/science.1081578
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban
Joachim P Schmitt et al. Science. 2003.
Abstract
Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg --> Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLN(R9C) mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLN(R9C) did not directly inhibit SERCA2a. Rather, PLN(R9C) trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.
Similar articles
- Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Schmitt JP, Ahmad F, Lorenz K, Hein L, Schulz S, Asahi M, Maclennan DH, Seidman CE, Seidman JG, Lohse MJ. Schmitt JP, et al. Circulation. 2009 Jan 27;119(3):436-44. doi: 10.1161/CIRCULATIONAHA.108.783506. Epub 2009 Jan 12. Circulation. 2009. PMID: 19139388 - Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A.
Ha KN, Masterson LR, Hou Z, Verardi R, Walsh N, Veglia G, Robia SL. Ha KN, et al. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2735-40. doi: 10.1073/pnas.1013987108. Epub 2011 Jan 31. Proc Natl Acad Sci U S A. 2011. PMID: 21282613 Free PMC article. - Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
Haghighi K, Gregory KN, Kranias EG. Haghighi K, et al. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1214-22. doi: 10.1016/j.bbrc.2004.07.164. Biochem Biophys Res Commun. 2004. PMID: 15336969 Review. - Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
Minamisawa S, Hoshijima M, Chu G, Ward CA, Frank K, Gu Y, Martone ME, Wang Y, Ross J Jr, Kranias EG, Giles WR, Chien KR. Minamisawa S, et al. Cell. 1999 Oct 29;99(3):313-22. doi: 10.1016/s0092-8674(00)81662-1. Cell. 1999. PMID: 10555147 - Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.
Young HS, Ceholski DK, Trieber CA. Young HS, et al. Biochem Cell Biol. 2015 Feb;93(1):1-7. doi: 10.1139/bcb-2014-0080. Epub 2014 Dec 1. Biochem Cell Biol. 2015. PMID: 25563649 Review.
Cited by
- Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation.
Stege NM, de Boer RA, Makarewich CA, van der Meer P, Silljé HHW. Stege NM, et al. JACC Basic Transl Sci. 2024 Apr 17;9(8):1041-1052. doi: 10.1016/j.jacbts.2024.02.017. eCollection 2024 Aug. JACC Basic Transl Sci. 2024. PMID: 39297138 Free PMC article. Review. - Probing the formation of a hetero-dimeric membrane transport complex with dual in vitro and in silico mutagenesis.
Rathod N, Lemieux MJ, Chipot C, Roux B, Young HS. Rathod N, et al. Chem Sci. 2024 Aug 6;15(35):14310-22. doi: 10.1039/d4sc02915a. Online ahead of print. Chem Sci. 2024. PMID: 39156929 Free PMC article. - Pediatric dilated cardiomyopathy: a review of current clinical approaches and pathogenesis.
Malinow I, Fong DC, Miyamoto M, Badran S, Hong CC. Malinow I, et al. Front Pediatr. 2024 Jun 19;12:1404942. doi: 10.3389/fped.2024.1404942. eCollection 2024. Front Pediatr. 2024. PMID: 38966492 Free PMC article. Review. - In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin.
Shao Y, Liu C, Liao HK, Zhang R, Yuan B, Yang H, Li R, Zhu S, Fang X, Rodriguez Esteban C, Chen J, Izpisua Belmonte JC. Shao Y, et al. Genome Biol. 2024 May 23;25(1):135. doi: 10.1186/s13059-024-03283-x. Genome Biol. 2024. PMID: 38783323 Free PMC article. - A Heterozygous Phospholamban Variant (p.R14del) Leads to Left Ventricular Involvement and Heart Failure Phenotypes in Arrhythmogenic Right Ventricular Cardiomyopathy.
Mo H, Hua X, Bao M, Sun Z, Chen X, Xu M, Song J. Mo H, et al. Phenomics. 2024 Jan 29;4(1):13-23. doi: 10.1007/s43657-023-00126-w. eCollection 2024 Feb. Phenomics. 2024. PMID: 38605909
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous